Obesity and COVID-19: renin-angiotensin as a mediator of morbidity and mortality
Br J Nutr
.
2022 May 14;127(9):1439-1440.
doi: 10.1017/S0007114521001847.
Epub 2021 Jun 3.
Authors
Jennifer H Martin
1
,
Richard E Head
2
Affiliations
1
Centre for Drug Repurposing and Medicines Research, Clinical Pharmacology, University of Newcastle, NSW2305, Australia.
2
University of South Australia, Adelaide, SA5002, Australia.
PMID:
34078498
PMCID:
PMC8376908
DOI:
10.1017/S0007114521001847
No abstract available
MeSH terms
Angiotensins
COVID-19*
Humans
Hypertension*
Morbidity
Obesity
Renin
Renin-Angiotensin System
Substances
Renin
Angiotensins